- Home
- ESPR vs SEG Comparison
ESPR vs SEG Comparison
Compare ESPR & SEG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESPR
- SEG
- Stock Information
- Founded
- ESPR 2008
- SEG 2024
- Country
- ESPR United States
- SEG United States
- Employees
- ESPR N/A
- SEG N/A
- Industry
- ESPR Biotechnology: Pharmaceutical Preparations
- SEG
- Sector
- ESPR Health Care
- SEG
- Exchange
- ESPR Nasdaq
- SEG NYSE
- Market Cap
- ESPR 399.0M
- SEG 347.0M
- IPO Year
- ESPR 2013
- SEG N/A
- Fundamental
- Price
- ESPR $2.30
- SEG $27.52
- Analyst Decision
- ESPR Buy
- SEG
- Analyst Count
- ESPR 5
- SEG 0
- Target Price
- ESPR $7.30
- SEG N/A
- AVG Volume (30 Days)
- ESPR 8.8M
- SEG 77.1K
- Earning Date
- ESPR 11-07-2024
- SEG 02-05-2025
- Dividend Yield
- ESPR N/A
- SEG N/A
- EPS Growth
- ESPR N/A
- SEG N/A
- EPS
- ESPR N/A
- SEG N/A
- Revenue
- ESPR $295,451,000.00
- SEG $111,487,000.00
- Revenue This Year
- ESPR $186.90
- SEG N/A
- Revenue Next Year
- ESPR $31.10
- SEG N/A
- P/E Ratio
- ESPR N/A
- SEG N/A
- Revenue Growth
- ESPR 187.12
- SEG 36.09
- 52 Week Low
- ESPR $1.58
- SEG $22.51
- 52 Week High
- ESPR $3.94
- SEG $36.50
- Technical
- Relative Strength Index (RSI)
- ESPR 44.79
- SEG N/A
- Support Level
- ESPR $2.12
- SEG N/A
- Resistance Level
- ESPR $2.54
- SEG N/A
- Average True Range (ATR)
- ESPR 0.35
- SEG 0.00
- MACD
- ESPR -0.10
- SEG 0.00
- Stochastic Oscillator
- ESPR 21.90
- SEG 0.00
About ESPR Esperion Therapeutics Inc.
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The Company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.
About SEG SEAPORT ENTERTAINMENT GROUP INC
Seaport Entertainment Group Inc own, operate and develop a unique collection of assets positioned at the intersection of entertainment and real estate. Its objective is to integrate one-of-a-kind real estate assets with a variety of restaurant, retail and leisure offerings to form vibrant mixed-use destinations where customers can work, play and socialize in one cohesive setting. The company has three operating segments: (1) Landlord Operations; (2) Hospitality; and (3) Sponsorships, Events, and Entertainment. Key revenue is generated from Landlord Operations which consists of the company's rental operations.